Geopolitics & Trade

As the surety market faces new challenges, Rosenberg & Parker brings in Michael Bogansky to fortify its financial strategy for a new era of expansion.

AI identity firm Trust Stamp unveils a bold 2026 plan, targeting acquisitions, African markets, and the stablecoin economy to fuel its global expansion.

A new campaign from ZOLL LifeVest and the AHA targets the deadly disparity in women's cardiac care, blending advocacy with life-saving wearable technology.

A new PropTech firm is challenging automated home estimates with bestimation™, an expert-audited valuation designed to give homeowners 'Truth Data'.

Investors sue medical device maker Integer Holdings, alleging misleading statements led to a catastrophic 32% stock drop. What went wrong behind the scenes?

Cybersecurity firm Cynet appoints industry veteran MacKenzie Brown to translate complex threat data into practical, actionable intelligence for MSP partners.

A new report warns one in five malware infections will expose corporate logins by late 2026 as attackers pivot to high-value enterprise identity platforms.

Burberry and Coty launch Hero Elixir, a potent new fragrance exploring duality and competing in the high-stakes, ultra-premium men's scent market.

The acquisition expands Connect Media beyond its real estate stronghold, creating a diversified giant in the competitive B2B information and events market.

With a major Phase 3 trial now in Europe, Crystalys Therapeutics aims to fill a critical gap in gout care with a drug already proven in Asian markets.

Automotive giant Garrett Motion enters the HVAC market with oil-free tech, promising major energy savings and a greener future for commercial buildings.

Madison Square Garden's theater is renamed as part of an expanded deal, leveraging AI to redefine the fan experience for sports and entertainment.

Shanghai's AI EdTech innovator Jinxin faces a potential Nasdaq delisting after its stock plummets, putting its high-tech vision against market reality.

Smashing its target, Hamilton Lane's new fund highlights intense investor appetite for assets powering AI, logistics, and the energy transition.

Mwyngil Therapeutics starts clinical trials for a novel brain-penetrating drug, aiming to tackle neuroinflammation at its source in MS and Parkinson's.

A state-funded grant unites UCLA and industry to create a scientific benchmark for cannabis flavors, aiming to enhance public safety and regulatory clarity.

A new FAIR Health report finds 57.5% of commercially insured Americans have a chronic condition, with costs nearly doubling for patients with just one.

Offshore driller Foresea doubles its cash offer to amend debt rules, seeking flexibility for $175M in payments, a move that alters its risk profile.

Brainomix launches its award-winning stroke AI platform with novel Net Water Uptake tech, promising to improve diagnoses, treatment decisions, and patient outcomes.

Amid strategic uncertainty after a rejected takeover, STAAR Surgical appoints two veteran executives as interim co-CEOs while launching a global search.